Health Care: Drugs

Cyclacel Pharmaceuticals Inc. (CYCC: NASDAQ)

$3.28 0.11 | 3.47%
04/17/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 3.28
52 Week High 5.50
52 Week Low 2.75
Avg. Daily Vol. (Mil) 0.17
Beta (3 year) 2.30
Share Related Items
Mkt Cap (Mil) 65.01
Shares Out (Mil) 19.82
Float (Mil) 19.08
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.20
Current Ratio 4.70
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 59.97
Price/Book 2.32
Price/Cash Flow -3.30
Per Share Data
Earnings -1.28
Sales 0.05
Book Value 1.41
Cash Flow -0.98
Business Summary
Cyclacel Pharmaceuticals, Inc., is a development-stage biopharmaceutical company engaged in the development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious diseases.
General Information
200 Connell Drive
Suite 1500
Berkeley Heights, NJ 07922
www.cyclacel.com
Industry : Drugs
Sector: Health Care
Employees: 18
CEO: Spiro Rombotis
Short Interest
Current Month (Mil) 1.91
Previous Month (Mil) 1.80
Short Interest Ratio (Days) 12.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -28.60
Return on Investments -36.20
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with CYCC

Latest CYCC Headlines from TheStreet

More Financial News for CYCC

Press Releases for CYCC

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter